Connors Investor Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,013
Closed -$260K 149
2019
Q1
$260K Sell
3,013
-558
-16% -$44.8K 0.04% 123
2018
Q4
$275K Sell
3,571
-1,157
-24% -$90.1K 0.04% 108
2018
Q3
$365K Buy
4,728
+1,157
+32% +$85.5K 0.05% 106
2018
Q2
$242K Hold
3,571
0.03% 129
2018
Q1
$259K Hold
3,571
0.04% 125
2017
Q4
$269K Hold
3,571
0.04% 124
2017
Q3
$275K Sell
3,571
-223
-6% -$16.8K 0.04% 120
2017
Q2
$284K Hold
3,794
0.04% 122
2017
Q1
$253K Sell
3,794
-1,228
-24% -$81.8K 0.04% 131
2016
Q4
$328K Hold
5,022
0.06% 113
2016
Q3
$355K Sell
5,022
-558
-10% -$40.7K 0.06% 107
2016
Q2
$413K Hold
5,580
0.08% 100
2016
Q1
$362K Sell
5,580
-94
-2% -$6.39K 0.07% 106
2015
Q4
$437K Hold
5,674
0.09% 97
2015
Q3
$467K Buy
+5,674
New +$505K 0.11% 97
2015
Q2
Sell
-7,906
Closed -$699K 160
2015
Q1
$699K Buy
7,906
+1,116
+16% +$99K 0.15% 94
2014
Q4
$564K Sell
6,790
-223
-3% -$18.5K 0.13% 99
2014
Q3
$592K Hold
7,013
0.14% 96
2014
Q2
$569K Hold
7,013
0.14% 96
2014
Q1
$534K Hold
7,013
0.13% 97
2013
Q4
$505K Hold
7,013
0.13% 99
2013
Q3
$482K Hold
7,013
0.14% 100
2013
Q2
$444K Buy
+7,013
New +$456K 0.14% 98

Other funds holding NVS

Connors Investor Services's NVS Position: Q2 2019 in Review

Connors Investor Services sold out of Novartis (NVS) in Q2 2019, closing a stake of 3,013 shares — an estimated $260K sold.

Connors Investor Services first reported a position in NVS in Q2 2013 and held it in 23 quarters. The position peaked at $699K in Q1 2015. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

  • Connors Investor Services reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
  • Connors Investor Services sold 3,013 Novartis shares in Q2 2019, an estimated $260K.
  • Connors Investor Services first reported a position in Novartis in Q2 2013 and held it in 23 quarters.
  • Connors Investor Services's Novartis position peaked at $699K in Q1 2015.
  • 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Connors Investor Services's 13F filing for Q2 2019, filed 14 Aug 2019.